Here is the latest letter as posted at the other forum from Bogus/Bogie of the other forum, this one to Mario, the latest Hail Mary hope.
Keep in mind that Bogey/Booger has written to just about every BP Company and World Goverment on earth imploring them to buy Ocata as the Stock of a Lifetime with obviously no responses and/or positive ones or else I am sure he would have posted them.
Will this time be different and will Mario be in fact the White Knight who comes running over and makes how own bid to save Ocata shareholders from the Evil "Borg" Astellas which wants to assimilate Ocata into its empire or will he just yawn and consider it just one of the zillion letters I am sure he has received over the years from other advocates from other companies stating that their company is the stock of the century-stay tuned folks as the next exciting episode of Ocata Turns unfolds before your own EYES,that is if you are not appropriately in this case BLIND:
An Open Letter to Mario Gabelli
Mr. Gabelli,
First off, on behalf of myself and hundreds of Ocata Therapeutics retail shareholders we would like to congratulate and thank you for taking a +5% position in Ocata Therapeutics.
We hope that your interest is much more than an arbitrage play and as one of the world's best value players in the market today, that you too have recognized not only Dr. Lanza's brilliance but also how under valued his company is.
As I'm sure you know, Dr. Lanza is one of the top Regenerative Scientists in the world and his company with around 150 patents and pending patents control almost all cell types created from a blastomere and IPSC. They have 7 FDA approved clinical trials underway covering the US, UK and Korea, using uniquely derived RPE cells for the treatment of AMD/SMD/MMD, one of the world's largest unmet medical conditions, and to date are having great success as recent published results in the Lancet show. Including the reported "Cowboy patient" who went from legally blind 20/400 to able to get a driver's license with 20/40 vision within 60-90 days after a single injection, nearly 3 years ago.
Dr. Lanza and his team also have many published papers from pre-clinical studies where they have shown their MSC's have greatly reversed MS, Lupus and Crohn's disease in mice, rats and canines after a single injection. They have even shown using their patented Hemangioblast science, the ability to produce scalable, universal blood and platelets.
So yes hundreds of retail investors agree with your investment and insight that Ocata may be a true diamond in the rough.
Now comes the fun part. You have done many things in your life and at 72, I hope you might be looking for something very meaningful that you can leave the world and I hope by your recent investment that it might be to help propel Dr. Lanza's potentially curative science forward where billions of people will benefit in the decades to come.
But in order to do this a change in leadership within the company is critical IMO. As you know Astelles, a Japanese firm has a tender offer underway which will move this US born science of Dr. Lanza and all of the patents over to Japan's control. The vote count is currently a virtual tie with each side controlling about 36% of the outstanding shares based on your recent investment and what was published back in mid December so it is critical another 14% does not slide over to Astelles.
To gain control of this company we need around 6m more shares in the non tender column coupled with the current 15.3M shares that are a firm NO TENDER and hope between you and your peers that we can lock these final shares down, move forward with a new BOD, keep this American born science under the USA flag and get this science and these trials back on track.
As your history shows, you too recognize there are times when a company has a great product/solution but a change at the BOD and executive level is required for the company to reach its full potential and IMO this is one of those times so your leadership would be greatly appreciated in helping to bring about this change.
Ocata's AMD/SMD trials have been approved for phase 2 with Orphan, ATMP and pivitol status from the EMA approved for SMD. Within 12-24 months, data and results from phase 2 will be available and as you know this is typically when Big Pharma gets really interested and makes their move. The market opportunity for just AMD/SMD alone is well over $600B with over 30M in the US and UK afflicted with macular degeneration. It is important to note that losing ones sight is the second biggest fear people have next to getting cancer and today there is no real treatment or cure for AMD.
The loyal retail shareholder base that I mentioned which discusses and tracks Ocata's shareholder count daily is at Investor Stemcell and I encourage you to stop by, browse and post if you like.
I congratulate you for your vision and boldness and hope your motivation is not only to make money on your new investment but also be a catalyst for a game changing solution within the healthcare industry that can eventually help millions move away from their pill popping addiction and begin to bring about real cures for the world.
Thanks again for stepping up with your significant purchase and I truly believe with your help and Dr. Lanza's science we can help usher in real change within the healthcare industry.
Kind Regards,
BF
